Cure My Disease

Don't miss your cure!

 Log in / Sign up

New imaging tech could sharpen vision after cataract surgery

NCT ID NCT07436247

Recruiting now Knowledge-focused Sponsor: Prim. Prof. Dr. Oliver Findl, MBA Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study involves 80 adults who have had cataract surgery and received special lens implants that correct presbyopia (age-related blurry near vision). Researchers will use a 3-D eye scanner and a wavefront sensor to measure how well these lenses focus light onto the retina. The goal is to understand which lens designs provide the best image quality, helping surgeons make better choices in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this could help doctors choose better lens implants for cataract patients, improving their vision quality after surgery.
What could go wrong
This is an observational study, not a treatment trial. It only measures outcomes and does not test a new therapy, so it won't directly change patient care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

    RECRUITING

    Vienna, 1140, Austria

  • Vienna Institute for Research in Ocular Surgery (VIROS), Hanusch Hospital Vienna

    RECRUITING

    Vienna, 1140, Austria

    Contact Email: •••••@•••••

    Contact Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.